检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
机构地区:[1]中南大学湘雅三医院乳疝外科,湖南长沙410018
出 处:《中国现代医学杂志》2016年第8期17-21,共5页China Journal of Modern Medicine
摘 要:目的探讨长链非编码GATS对乳腺癌细胞增殖和侵袭的影响。方法构建的人LncRNA-GATSsh RNA1-4慢病毒载体转染乳腺癌MDA-MB-231细胞后,qPCR筛选出干扰效率为50.0%和54.0%的sh1组和sh3组,MTT法和Transwell实验分别检测转染后细胞增殖和侵袭能力;流式细胞术检测转染sh1组慢病毒后细胞周期分布及凋亡变化。结果测序证实,LncRNA-GATS的sh RNA寡聚核苷酸序列已被克隆到pLV-GATS载体;转染MDA-MB-231细胞后,与阴性对照组比较,sh1组和sh3组的乳腺癌细胞增殖和侵袭能力均降低(P〈0.01),以sh1组更显著;sh1组细胞周期被阻滞于S期(P〈0.01);细胞凋亡率无明显变化(P〉0.05)。结论 LncRNA-GATS可能下调乳腺癌细胞侵袭力,并通过抑制细胞周期进展降低细胞增殖能力。Objective To investigate the effect of human long non-coding RNA GATS on proliferation and invasion of breast cancer MDA-MB-231 cells. Methods Four human GATS-lnc RNA-specific oligonucleotide sequences were designed and synthesized previously, then were inserted into the pLV-GATS vector. After infecting the MDAMB-231 cells, transfection efficiencies of GATS-lnc RNA-sh RNA1 and GATS-lnc RNA-sh RNA3 were analyzed and screened by qPCR, which were 50.0% and 54.0% respectively. MTT and Transwell assays were used to detect the proliferation and invasion ability of the transfected cells, respectively. Flow cytometry was used to search the changes of cell cycle distribution and apoptosis of the MDA-MB-231 cells transfected GATS-lnc RNA-sh RNA1 lentiviral vector. Results Compared with the cells transfected with scrambled sh RNA, the proliferation and invasion ability of cells the sh1 group and sh3 group was inhibited, especially t- hose the sh1 group. Flow cytometry showed the sh1 group cell cycle was arrested in S phase, and the cell apoptosis rate had no significant change(P 0.05).Conclusions lnc RNA GATS inhibits the invasion of breast cancer cells, and down regulates the proliferation of tumor cells through arresting cell cycle in S phase.
关 键 词:人 LncRNA-GATS shRNA干扰载体 MDA-MB-231细胞 增殖 侵袭
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:18.117.9.230